Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
Nayab Tahir,1–3 Asadullah Madni,2 Alexandra Correia,3 Mubashar Rehman,4 Vimalkumar Balasubramanian,3 Muhammad Muzamil Khan,2 Hélder A Santos3,51College of Pharmacy, University of Sargodha, Sargodha, Pakistan; 2Department of Pharmacy, The Islamia University of Bahawalpur, Bahawal...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-07-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/lipid-polymer-hybrid-nanoparticles-for-controlled-delivery-of-hydrophi-peer-reviewed-article-IJN |
| _version_ | 1818844100608131072 |
|---|---|
| author | Tahir N Madni A Correia A Rehman M Balasubramanian V Khan MM Santos HA |
| author_facet | Tahir N Madni A Correia A Rehman M Balasubramanian V Khan MM Santos HA |
| author_sort | Tahir N |
| collection | DOAJ |
| description | Nayab Tahir,1–3 Asadullah Madni,2 Alexandra Correia,3 Mubashar Rehman,4 Vimalkumar Balasubramanian,3 Muhammad Muzamil Khan,2 Hélder A Santos3,51College of Pharmacy, University of Sargodha, Sargodha, Pakistan; 2Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan; 3Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland; 4Department of Pharmacy, The University of central Pujnab, Lahore, Pakistan; 5Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki FI-00014, FinlandBackground: Lipid polymer hybrid nanoparticles (LPHNPs) for the controlled delivery of hydrophilic doxorubicin hydrochloride (DOX.HCl) and lipophilic DOX base have been fabricated by the single step modified nanoprecipitation method.Materials and methods: Poly (D, L-lactide-co-glicolide) (PLGA), lecithin, and 1,2-distearoyl-Sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000 (DSPE-PEG 2000) were selected as structural components.Results: The mean particle size was 173–208 nm, with an encapsulation efficiency of 17.8±1.9 to 43.8±4.4% and 40.3±0.6 to 59. 8±1.4% for DOX.HCl and DOX base, respectively. The drug release profile was in the range 33–57% in 24 hours and followed the Higuchi model (R2,=0.9867–0.9450) and Fickian diffusion (n<0.5). However, the release of DOX base was slower than DOX.HCl. The in vitro cytotoxicity studies and confocal imaging showed safety, good biocompatibility, and a higher degree of particle internalization. The higher internalization of DOX base was attributed to higher permeability of lipophilic component and better hydrophobic interaction of particles with cell membranes. Compared to the free DOX, the DOX.HCl and DOX base loaded LPHNPs showed higher antiproliferation effects in MDA-MB231 and PC3 cells.Conclusion: Therefore, LPHNPs have provided a potential drug delivery strategy for safe, controlled delivery of both hydrophilic and lipophilic form of DOX in cancer cells.Keywords: lipid polymer hybrid, doxorubicin, breast cancer, nanotechnology, drug delivery |
| first_indexed | 2024-12-19T05:08:24Z |
| format | Article |
| id | doaj.art-cba59940617b4730b2b16c2c36ffc50a |
| institution | Directory Open Access Journal |
| issn | 1178-2013 |
| language | English |
| last_indexed | 2024-12-19T05:08:24Z |
| publishDate | 2019-07-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of Nanomedicine |
| spelling | doaj.art-cba59940617b4730b2b16c2c36ffc50a2022-12-21T20:34:51ZengDove Medical PressInternational Journal of Nanomedicine1178-20132019-07-01Volume 144961497446897Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapyTahir NMadni ACorreia ARehman MBalasubramanian VKhan MMSantos HANayab Tahir,1–3 Asadullah Madni,2 Alexandra Correia,3 Mubashar Rehman,4 Vimalkumar Balasubramanian,3 Muhammad Muzamil Khan,2 Hélder A Santos3,51College of Pharmacy, University of Sargodha, Sargodha, Pakistan; 2Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan; 3Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki FI-00014, Finland; 4Department of Pharmacy, The University of central Pujnab, Lahore, Pakistan; 5Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki FI-00014, FinlandBackground: Lipid polymer hybrid nanoparticles (LPHNPs) for the controlled delivery of hydrophilic doxorubicin hydrochloride (DOX.HCl) and lipophilic DOX base have been fabricated by the single step modified nanoprecipitation method.Materials and methods: Poly (D, L-lactide-co-glicolide) (PLGA), lecithin, and 1,2-distearoyl-Sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000 (DSPE-PEG 2000) were selected as structural components.Results: The mean particle size was 173–208 nm, with an encapsulation efficiency of 17.8±1.9 to 43.8±4.4% and 40.3±0.6 to 59. 8±1.4% for DOX.HCl and DOX base, respectively. The drug release profile was in the range 33–57% in 24 hours and followed the Higuchi model (R2,=0.9867–0.9450) and Fickian diffusion (n<0.5). However, the release of DOX base was slower than DOX.HCl. The in vitro cytotoxicity studies and confocal imaging showed safety, good biocompatibility, and a higher degree of particle internalization. The higher internalization of DOX base was attributed to higher permeability of lipophilic component and better hydrophobic interaction of particles with cell membranes. Compared to the free DOX, the DOX.HCl and DOX base loaded LPHNPs showed higher antiproliferation effects in MDA-MB231 and PC3 cells.Conclusion: Therefore, LPHNPs have provided a potential drug delivery strategy for safe, controlled delivery of both hydrophilic and lipophilic form of DOX in cancer cells.Keywords: lipid polymer hybrid, doxorubicin, breast cancer, nanotechnology, drug deliveryhttps://www.dovepress.com/lipid-polymer-hybrid-nanoparticles-for-controlled-delivery-of-hydrophi-peer-reviewed-article-IJNDoxorubicin hydrochloridelipid polymer hybridnanoparticlescancerdrug delivery |
| spellingShingle | Tahir N Madni A Correia A Rehman M Balasubramanian V Khan MM Santos HA Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy International Journal of Nanomedicine Doxorubicin hydrochloride lipid polymer hybrid nanoparticles cancer drug delivery |
| title | Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy |
| title_full | Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy |
| title_fullStr | Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy |
| title_full_unstemmed | Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy |
| title_short | Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy |
| title_sort | lipid polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy |
| topic | Doxorubicin hydrochloride lipid polymer hybrid nanoparticles cancer drug delivery |
| url | https://www.dovepress.com/lipid-polymer-hybrid-nanoparticles-for-controlled-delivery-of-hydrophi-peer-reviewed-article-IJN |
| work_keys_str_mv | AT tahirn lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapy AT madnia lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapy AT correiaa lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapy AT rehmanm lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapy AT balasubramanianv lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapy AT khanmm lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapy AT santosha lipidpolymerhybridnanoparticlesforcontrolleddeliveryofhydrophilicandlipophilicdoxorubicinforbreastcancertherapy |